Data / Drug companies / Lisinopril and hydrochlorothiazide
Lisinopril and hydrochlorothiazide: 21 companies and 57 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Lisinopril and hydrochlorothiazide is listed in the FDA National Drug Code Directory by 21 companies, with 57 products in commercial distribution. 54 of the products (94.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on November 2, 2026.
The request: Get every company that lists lisinopril and hydrochlorothiazide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 21
- Products
- 57
- Generic (ANDA) products
- 54 (94.7%)
- Application numbers
- 6
- Routes
- Oral
- Brand names
- Zestoretic
- openFDA record search
- api.fda.gov
Companies that list lisinopril and hydrochlorothiazide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| NuCare Pharmaceuticals,Inc. | 5 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| A-S Medication Solutions | 4 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| Northwind Health Company, LLC | 4 | tablet | Generic drugs (ANDA) | July 14, 2022 |
| Proficient Rx LP | 4 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| Actavis Pharma, Inc. | 3 | tablet | Generic drugs (ANDA) | March 4, 2003 |
| Almatica Pharma LLC | 3 | tablet | New drug applications (NDA) | April 15, 2015 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | March 14, 2006 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | February 15, 2025 |
| Legacy Pharmaceutical Packaging, LLC | 3 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| Lupin Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| Preferred Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | April 23, 2012 |
| Remedyrepack Inc. | 3 | tablet | Generic drugs (ANDA) | April 3, 2017 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| Bryant Ranch Prepack | 2 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| Coupler LLC | 2 | tablet | Generic drugs (ANDA) | November 2, 2026 |
| QPharma, Inc. | 2 | tablet | Generic drugs (ANDA) | October 4, 2006 |
| Advanced Rx of Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | November 4, 2022 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | April 10, 2006 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | May 16, 2013 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 57 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 54 | 94.7% |
| New drug applications (NDA) | 3 | 5.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin Converting Enzyme Inhibitor | 57 |
| Thiazide Diuretic | 57 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.